BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24882049)

  • 1. Role of interleukin 10 in norfloxacin prevention of luminal free endotoxin translocation in mice with cirrhosis.
    Gómez-Hurtado I; Moratalla A; Moya-Pérez Á; Peiró G; Zapater P; González-Navajas JM; Giménez P; Such J; Sanz Y; Francés R
    J Hepatol; 2014 Oct; 61(4):799-808. PubMed ID: 24882049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I improves intestinal barrier function in cirrhotic rats.
    Lorenzo-Zúñiga V; Rodríguez-Ortigosa CM; Bartolí R; Martínez-Chantar ML; Martínez-Peralta L; Pardo A; Ojanguren I; Quiroga J; Planas R; Prieto J
    Gut; 2006 Sep; 55(9):1306-12. PubMed ID: 16434425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bifidobacterium pseudocatenulatum CECT7765 promotes a TLR2-dependent anti-inflammatory response in intestinal lymphocytes from mice with cirrhosis.
    Moratalla A; Gómez-Hurtado I; Moya-Pérez Á; Zapater P; Peiró G; González-Navajas JM; Gómez Del Pulgar EM; Such J; Sanz Y; Francés R
    Eur J Nutr; 2016 Feb; 55(1):197-206. PubMed ID: 25657013
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective intestinal decontamination with norfloxacin enhances a regulatory T cell-mediated inflammatory control mechanism in cirrhosis.
    Juanola O; Gómez-Hurtado I; Zapater P; Moratalla A; Caparrós E; Piñero P; González-Navajas JM; Giménez P; Such J; Francés R
    Liver Int; 2016 Dec; 36(12):1811-1820. PubMed ID: 27214392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FXR modulates the gut-vascular barrier by regulating the entry sites for bacterial translocation in experimental cirrhosis.
    Sorribas M; Jakob MO; Yilmaz B; Li H; Stutz D; Noser Y; de Gottardi A; Moghadamrad S; Hassan M; Albillos A; Francés R; Juanola O; Spadoni I; Rescigno M; Wiest R
    J Hepatol; 2019 Dec; 71(6):1126-1140. PubMed ID: 31295531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut derived-endotoxin contributes to inflammation in severe ischemic acute kidney injury.
    Li J; Moturi KR; Wang L; Zhang K; Yu C
    BMC Nephrol; 2019 Jan; 20(1):16. PubMed ID: 30634931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Norfloxacin is more effective than Rifaximin in avoiding bacterial translocation in an animal model of cirrhosis.
    Gómez-Hurtado I; Gimenez P; García I; Zapater P; Francés R; González-Navajas JM; Manichanh C; Ramos JM; Bellot P; Guarner F; Such J
    Liver Int; 2018 Feb; 38(2):295-302. PubMed ID: 28834270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lactulose on intestinal endotoxin and bacterial translocation in cirrhotic rats.
    Zhang S; Wang W; Ren W; Dai Q; He B; Zhou K
    Chin Med J (Engl); 2003 May; 116(5):767-71. PubMed ID: 12875698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis.
    Runyon BA; Borzio M; Young S; Squier SU; Guarner C; Runyon MA
    Hepatology; 1995 Jun; 21(6):1719-24. PubMed ID: 7768517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protective effect of Bifidobacterium pseudocatenulatum CECT7765 against induced bacterial antigen translocation in experimental cirrhosis.
    Moratalla A; Gómez-Hurtado I; Santacruz A; Moya Á; Peiró G; Zapater P; González-Navajas JM; Giménez P; Such J; Sanz Y; Francés R
    Liver Int; 2014 Jul; 34(6):850-8. PubMed ID: 24267920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal flora imbalance results in altered bacterial translocation and liver function in rats with experimental cirrhosis.
    Zhang W; Gu Y; Chen Y; Deng H; Chen L; Chen S; Zhang G; Gao Z
    Eur J Gastroenterol Hepatol; 2010 Dec; 22(12):1481-6. PubMed ID: 20739895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of pentoxifylline on intestinal bacterial overgrowth, bacterial translocation and spontaneous bacterial peritonitis in cirrhotic rats with ascites.
    Corradi F; Brusasco C; Fernández J; Vila J; Ramirez MJ; Seva-Pereira T; Fernández-Varo G; Mosbah IB; Acevedo J; Silva A; Rocco PR; Pelosi P; Gines P; Navasa M
    Dig Liver Dis; 2012 Mar; 44(3):239-44. PubMed ID: 22119621
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of cisapride on intestinal bacterial and endotoxin translocation in cirrhotic rats].
    Zhang SC; Wang W; Ren WY; Zhou K; He BM; Zhu WN
    Zhonghua Gan Zang Bing Za Zhi; 2003 Sep; 11(9):539-41. PubMed ID: 14552714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal microbiota and innate immunity-related gene alteration in cirrhotic rats with liver transplantation.
    Xie YR; Liu SL; Liu X; Luo ZB; Zhu B; Li ZF; Li LJ; He Y; Jiang L; Li H; Ruan B
    Transplant Proc; 2011 Dec; 43(10):3973-9. PubMed ID: 22172882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of cisapride on intestinal bacterial and endotoxin translocation in cirrhosis.
    Zhang SC; Wang W; Ren WY; He BM; Zhou K; Zhu WN
    World J Gastroenterol; 2003 Mar; 9(3):534-8. PubMed ID: 12632513
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of granulocyte colony-stimulating factor in paclitaxel-induced intestinal barrier breakdown and bacterial translocation in rats.
    Zhang C; Xu YG; Duan XN; Liu YH; Zhao JX; Xu L; Ye JM
    Chin Med J (Engl); 2011 Jun; 124(12):1870-5. PubMed ID: 21866617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of artesunate supplementation on bacterial translocation and dysbiosis of gut microbiota in rats with liver cirrhosis.
    Chen YX; Lai LN; Zhang HY; Bi YH; Meng L; Li XJ; Tian XX; Wang LM; Fan YM; Zhao ZF; Han DW; Ji C
    World J Gastroenterol; 2016 Mar; 22(10):2949-59. PubMed ID: 26973391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of propranolol on the factors promoting bacterial translocation in cirrhotic rats with ascites.
    Pérez-Paramo M; Muñoz J; Albillos A; Freile I; Portero F; Santos M; Ortiz-Berrocal J
    Hepatology; 2000 Jan; 31(1):43-8. PubMed ID: 10613726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New findings about an 'old' drug: immunomodulatory effects of norfloxacin in cirrhosis.
    Gustot T
    J Hepatol; 2014 Oct; 61(4):725-6. PubMed ID: 24996045
    [No Abstract]   [Full Text] [Related]  

  • 20. Dead bacteria reverse antibiotic-induced host defense impairment in burns.
    Chen LW; Chen PH; Fung CP; Hsu CM
    J Am Coll Surg; 2014 Oct; 219(4):606-19. PubMed ID: 25241233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.